Hair Loss Guide

What Is the Hair Growth Cycle and Why Does It Matter for Treatment?

Understanding the hair growth cycle is not just academicz It has direct implications for how hair loss treatments work, why they take so long to produce visible results, and why...

Understanding the hair growth cycle is not just academicz It has direct implications for how hair loss treatments work, why they take so long to produce visible results, and why timing matters in clinical hair loss management. Most of the confusion patients have about treatment timelines, shedding after starting treatment, and what "working" actually looks like comes from not understanding the cycle. This article covers the biology of the cycle and translates it into practical guidance for patients on hair loss treatment.

The Four Phases of the Hair Cycle

Each hair follicle independently cycles through four phases:

Anagen (Growth): The active growth phase. The follicle is metabolically active, cells in the hair matrix are dividing rapidly, and the hair shaft is elongating from the root. On the scalp, anagen typically lasts two to seven years. The length of anagen determines the maximum length a hair can grow — people with very long hair have naturally long anagen phases. About 85–90% of scalp hairs are in anagen at any given time.

Catagen (Regression): A brief transitional phase lasting about two to three weeks. The hair matrix ceases dividing, the follicle contracts, and the hair shaft detaches from its blood supply. The hair becomes a club hair, anchored at the top of the shortened follicle but no longer growing. About 1–3% of scalp hairs are in catagen at any given time.

Telogen (Resting): The resting phase lasting about two to 3 months. The club hair sits in the follicle without growing. At the end of telogen, the new anagen hair pushes the club hair out as it begins growing, producing the shed hair. About 10–15% of scalp hairs are in telogen at any given time. Normal daily shedding of 50–100 hairs is the visible product of this phase ending.

Exogen (Shedding): Sometimes described as a distinct phase separate from telogen. During exogen, the club hair is actively released. The mechanisms controlling exogen are incompletely understood but appear to involve distinct molecular signals from those controlling the anagen-telogen transition.

Takeaway

The hair cycle is the reason hair loss treatment takes so long. Any treatment, whether finasteride, minoxidil, or PRP, acts on follicles that are at different stages of the cycle. Visible results cannot appear faster than the cycle itself allows.

How Androgenic Alopecia Disrupts the Cycle

In androgenetic alopecia, DHT progressively shortens the anagen phase of affected follicles with each successive cycle. A follicle that once spent five years in anagen may spend only two years, then one year, then 6 months. With each shortened anagen, the hair produced is shorter, thinner, and less pigmented.

Simultaneously, the telogen phase lengthens. Follicles spend more time resting and less time actively growing. Eventually, the anagen phase becomes so short (sometimes only weeks) that the hair produced is barely visible.

This process of progressive anagen shortening and follicle miniaturization is androgenetic alopecia. It takes years to reach the visible stages because the cycle is long.

Takeaway

Androgenetic alopecia is a cycle-level disease. DHT shortens anagen, lengthens telogen, and progressively reduces hair shaft caliber over successive cycles spanning years.

Why Treatments Take So Long

No treatment can produce hair overnight because hair growth is constrained by the cycle. The minimum time from follicle activation to visible hair is 6 to 12 months:

A follicle that re-enters anagen today will not produce a hair visible above the scalp surface for about four to 6 months

The hair produced in that anagen phase will continue to grow for months before it reaches enough length to be noticeable in the context of surrounding hair

This explains why all hair loss treatments (finasteride, dutasteride, minoxidil, PRP) require 6 to 12 months before outcomes can be fairly assessed. Any assessment before 12 months may underestimate the eventual response.

Takeaway

Do not assess treatment response before 12 months. The biology of the hair cycle makes faster assessment meaningless.

Shedding After Starting Treatment: Why It Happens

One of the most anxiety-producing phenomena in hair loss treatment is increased shedding in the first few months after starting minoxidil. This is called minoxidil-induced telogen effluvium and is paradoxically a sign that the treatment is working.

The mechanism: minoxidil accelerates the transition of resting telogen follicles into anagen. Follicles that were sitting in telogen are pushed into the anagen phase earlier than they would have been without treatment. As a new anagen hair begins growing, it pushes out the telogen club hair that was sitting above it — producing the shed.

This shed typically begins 2 to 4 weeks after starting minoxidil and can last two to 3 months. It resolves as the resting follicles complete their transition to anagen and active growth resumes.

Patients who stop treatment during this shedding phase (believing the treatment is causing hair loss) are stopping exactly when they should be expecting early regrowth.

Takeaway

Shedding after starting minoxidil is a sign of follicle activation, not treatment failure. The shed is the old telogen hair being displaced by new anagen growth. Stopping treatment at this stage is one of the most common treatment errors.

The Cycle and Seasonal Variation

Human hair loss is not purely seasonal, but follicle cycling does show modest seasonal variation in studies. A 2009 analysis of 823 women found that the proportion of hairs in telogen was highest in July and August, producing a shed that peaks in October and November.

This seasonal variation may partly explain why many people notice increased hair loss in autumn without any identifiable clinical cause. The shedding is real, but it is a normal reflection of the cycle rather than a pathological process.

Takeaway

Seasonal fluctuations in shedding are a normal reflection of the hair cycle, not a sign of disease. Autumn shedding is common and typically self-limiting.

Using the Cycle to Interpret Progress

Understanding the cycle helps patients interpret what they observe during treatment:

Increased shedding in the first 1–3 months of minoxidil: Expected. Continue treatment.

No visible improvement at 3 months: Expected. The cycle takes longer.

Visible improvement at 6–9 months: Early positive response. Continue treatment.

Optimal results at 12–24 months: The full cycle has had time to turn over. This is when definitive response assessment is most reliable.

Loss returns after stopping treatment: Expected. DHT was never permanently reduced. The follicles return to their pre-treatment miniaturization trajectory once DHT suppression or growth stimulation stops.

Takeaway

The hair cycle is the timeline for everything in hair loss treatment. Every milestone (response, shed, recovery, plateau) is related to the biology of the cycle. Summary

The hair cycle consists of four phases: anagen (growth, 2–7 years), catagen (regression, 2–3 weeks), telogen (rest, 2–3 months), and exogen (shedding). Androgenetic alopecia shortens anagen and lengthens telogen progressively over successive cycles, driven by DHT. All treatments work within the constraints of the cycle: visible results require 6 to 12 months because that is how long the cycle takes. Minoxidil-induced shedding in the first months of treatment is a sign of follicle activation, not failure. Seasonal shedding in autumn is a normal cycle variation.

References & Citations
  1. Paus, Ralf, and George Cotsarelis. "The biology of hair follicles." New England Journal of Medicine, vol. 341, no. 7, 1999, pp. 491–497.
  2. Stenn, Kurt S., and Radhakrishnan Paus. "Controls of hair follicle cycling." Physiological Reviews, vol. 81, no. 1, 2001, pp. 449–494.
  3. Messenger, Andrew G., and Julian Rundegren. "Minoxidil: mechanisms of action on hair growth." British Journal of Dermatology, vol. 150, no. 2, 2004, pp. 186–194.
  4. Shapiro, Jerry, and Nina Otberg. Hair Loss: Principles of Diagnosis and Management of Alopecia. CRC Press, 2015.
  5. Kunz, Martin, et al. "Seasonality of hair loss." Dermatology, vol. 218, no. 2, 2009, pp. 98–101.
  6. Kaufman, Keith D. "Androgens and alopecia." Molecular and Cellular Endocrinology, vol. 198, no. 1–2, 2002, pp. 89–95.
  7. Price, Vera H. "Treatment of hair loss." New England Journal of Medicine, vol. 341, no. 13, 1999, pp. 964–973.